Financings in medical technology for the month of June 2009 totaled just about $300 million. This sector is defined (in our partisan view) largely by companies competing in a device or equipment market for therapeutic applications, or products either directly competing against, or complementary with, those applications.
Capital markets remain tight, but these funding levels confirm the perceived value of medical technology innovations. Below are specific financings comprising the June total.
- Active Implants Closes $10M in Funding (polymer technology for hip/knee segments of orthopedics)
- Alphatec Spine Completes $10 Million Private Placement of Common Stock (implants and systems for the treatment of spine disorders)
- Anulex Technologies, Inc. Raises $10.2 Million in Series D (spinal disc preservation and anular repair)
- Cappella, Inc., secures $17 million in Series C funding (sidebranch stent technologies for bifurcation vascular disease)
- Catheter Connections, Inc., has raised $1.3 million in seed capital (device to prevent hospital-acquired infections caused by catheters)
- CoAxia has raised $21.5 million in a Series D financing (acute ischemic stroke treatment)
- Embrella Cardiovascular has closed a $5.1 million Series B round of financing (devices for embolic protection during cardiovascular procedures)
- Estech Completes Additional $8 Million Financing (RF surgical ablation, minimally invasive valve surgery and CABG products)
- Inspire Medical Systems received $17 million in Series B funding (implant for the treatment of obstructive sleep apnea)
- Interlace Medical raises $20.5 million (office based polypectomy and myomectomy)
- iRhythm Technologies, Inc., secures $6.5 million Series C (arrhythmia monitoring devices)
- I-Therapeutix has raised $15 million in Series C funding (hydrogel-based eye bandages)
- LifeBond Ltd. has raised $8 million in its second financing round (sealants and hemostats)
- Ophthonix, Inc., receives $25.9 million in Series A funding (high definition vision correction lenses)\
- PhysioSonics has raised $2 million in equity funding (brain blood flow monitor for stroke, head trauma)
- Proteus Biomedical secures $11 million in series B financing (micro-electromechanical systems (MEMS) for the treatment of congestive heart failure)
- Radiotherapy positioning start up Navotech raises $10m. in new round
- Spiracur has raised $20.3 million in Series B funding (device for wound healing)
- Stentys SAS has received $4.2 million in Series B financing (stents for coronary artery bifurcations)
- SynCardia Systems, Inc., has raised $10.3 million in a Series D round of funding (total artificial heart)
- Torax Medical receives $18M in venture capital funding (device for the treatment of acid reflux)
- Transcend Medical has raised $35 million of an anticipated $40 million in a second round financing. Raised $20 million in early June, added $15 million in late June (device for glaucoma treatment)
- TransEnterix has raised $21 million in a Series A financing round (single incision laparoscopic surgery)
- VytonUS has received $11 million of a planned $11.5 million Series B funding round (ultrasound ablation catheter for treating atrial fibrillation)
bookmark to
Medtech financings total $300 million in June
Trackbacks & Pingbacks 1
[...] banks — there is indeed capital flowing into medtech (see July month-to-date financings and June transactions). And this is occuring without considering the very large amount of funds sitting in the [...]
Post a Comment